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Abstract
Introduction. Longitudinally extensive transverse myelitis
(LETM) is a transversal myelitis that extends through three
or more vertebral segments in length. Case report. A 52-
year-old woman was hospitalized due to pain in the lumbar
region, difficulty in walking, hypoesthesia of the anogenital
area and urinary retention. In the past medical history, two
years earlier, the patient had been diagnosed with transversal
myelitis confirmed by MRI of the cervical spine and six
months earlier, the patient was diagnosed with primary Sjö-
gren’s syndrome (SS). During the current hospitalization
MRI of the spinal cord revealed extensive inflammatory le-
sions of almost the whole spinal cord. Lumbar puncture
(LP) revealed mild pleocytosis and slightly increased protein
level. Isoelectric focusing of cerebrospinal fluid (CSF) and
serum proteins was normal. Visual evoked potentials were
normal. Serological testing excluded acute viral infections.
Corticosteroid therapy was applied with good therapeutic
response. Control MRI revealed regression of pathological
changes in the spinal cord. Conclusion. A wide range of
disorders can cause LETM, but usually the first line diagno-
sis is neuromyelitis optica (NMO). Based on the detection
of NMO immunoglobulin G in the serum of affected pa-
tients, a variety of allied disorders were grouped under the
name of NMO spectrum disorders, including recurrent
myelitis associated with LETM and myelitis associated with
autoimmune disorders such as SS. There have been only a
few cases reported in the literature with recurrent LETM as-
sociated with non-organ specific autoimmune disorder.
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Apstrakt
Uvod. Longitudinalno ekstenzivni transverzalni mijelitis
(LETM) je transverzalni mijelitis koji zahvata tri ili više su-
sednih segmenata kiÿmene moždine. Prikaz bolesnice.
Bolesnica, stara 52 godine, hospitalizovana je zbog bolova u
lumbalnom delu kiÿme, otežanog hoda, hipestezije anoge-
nitalne regije i retencije urina. Pre dve godine, magnetnom
rezonancom (MR) cervikalne kiÿme dijagnostikovan joj je
transverzalni mijelitis, a pre šest meseci primarni Sjegrenov
sindrom (SS). Tokom sadašnje hospitalizacije MR kiÿmenog
stuba verifikovana je ekstenzivna inflamatorna lezija koja je
zahvatala kiÿmenu moždinu skoro celom dužinom. Anali-
zom likvora utvrĀena je blaga pleocitoza i blaga hiperpro-
teinorahija. Nalaz izoelektriÿnog fokusiranja proteina likvora
i seruma bio je uredan, kao i nalaz vizuelnih evociranih po-
tencijala. Serološkim testovima iskljuÿena je akutna virusna
infekcija. Ordinirana je kortikosteroidna terapija uz dobar
terapijski odgovor. Kontrolnim nalazom MR potvrĀena je
regresija inflamatorne promene kiÿmene moždine. Zaklju-
ÿak. Brojne bolesti i poremeýaji mogu uzrokovati LETM,
ali na prvom mestu neuromijelitis optika (NMO). Na osno-
vu detekcije NMO imunoglobulina G u serumu bolesnika,
brojne srodne bolesti grupisane su pod imenom NMO spe-
ktar bolesti, koji ukljuÿuje rekurentni mijelitis povezan sa
LETM, kao i transverzalni mijelitis u sklopu autoimunih
oboljenja kao što je SS. U literaturi je opisano samo nekoli-
ko sluÿajeva rekurentnog LETM povezanog sa organ nespe-
cifiÿnim autoimunim bolestima.
Kljuÿne reÿi:
mijelitis, transverzalni; sjegrenov sindrom;
neuromijelitis optika; dijagnoza; leÿenje lekovima;
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Introduction
Longitudinally extensive transverse myelitis (LETM) is
a relatively recent term designating a transversal myelitis
(TM) that extends through three or more vertebral segments
in length 
1. It is much rarer and has more severe prognosis
than other types of TM. LETM is usually associated with
neuromyelitis optica (NMO), but as a possible diagnosis
systemic autoimmune diseases [Sjögren’s syndrome (SS),
systemic lupus erythematosus (SLE), antiphospholipid syn-
drome], neuroinflammatory conditions (Behcet’s disease,
sarcoidosis), multiple sclerosis (MS), and infectious diseases
should always be considered 
2.
Case report
A 52-year-old woman suddenly felt severe pain in the
right lumbar region without irradiation. Two days later, the
patient noticed difficulty in walking and hypoesthesia of the
anogenital area accompanied with urinary retention. Since the
patient had had similar problems before, she immediately
contacted the physician who referred her to our hospital.
Regarding the past medical history from other hospital
center, the patient had been diagnosed with TM confirmed by
magnetic resonance imaging (MRI) of the cervical spine that
showed intramedullary lesion extending from medulla oblongata
downwards to Th3 level of the spinal cord (Figure 1A), two
years earlier. At that time, computed tomography (CT) scan of
the brain revealed no abnormalities. Lumbar puncture (LP)
showed increased cell count with lymphocyte predomination.
Serological laboratory tests of serum and cerebrospinal fluid
(CSF) for common viruses and Borrelia burgdorferi were nega-
tive. The deficit that remained after the rehabilitation treatment
was discrete muscular weakness of the left arm and the right leg.
Control MRI of the cervical spine, performed tree times in a 2-
year period, revealed regression of pathological changes in the
spinal cord. Meanwhile, after some period of pain, swelling and
stiffness in both hands and feet, in the Institute for Rheumatol-
ogy the patient was diagnosed as primary SS based on: clinical
findings (xerophtalmia, xerostomia) laboratory findings [posi-
tive antinuclear antibodies (ANA), anti Ro/SS-A antibodies,
rheumatoid factor (RF)], ultrasound of salivary glands (focal ar-
eas of inflammation)]. It is important to emphasize the fact that
patient did not use the prescribed therapy – hydroxychloroquine.
On current admission to our neurological department, the
patient was alert, orientated, with all vital signs within normal
limits. Neurological findings were as follows: deviation of
tongue to the right, mild to moderate quadriparesis with in-
creased tendon reflexes, hypoesthesia of all extremities with a
level of decreased sensibility on Th4 dermatome and below,
urinary retention and obstipation.
Standard laboratory tests showed elevated sedimentation
rate, and mild anemia. C-reactive protein (CRP) level was
normal and lactate dehydrogenase (LDH) elevated. MRI of the
spinal cord revealed extensive inflammatory lesions of almost
the whole spinal cord (Figure 1 B). MRI of the brain showed a
few confluent T2W and fluid attenuated inversion recovery
(FLAIR) hyperintense lesions of brainstem and cerebellum.
Lumbar puncture revealed pleocytosis (101/mm³) with lym-
phocyte predomination (82%) and increased protein level
(0.82 g/L). Isoelectric focusing of CSF and serum proteins was
normal. Visual evoked potentials (VEP) were normal. Ab-
dominal ultrasound showed only liver hemangioma. Chest x-
ray was without pathological changes. Serological testing for
viruses, in consultation with an immunologist and infectolo-
gist, excluded acute viral infections.
A B
Fig. 1 – Magnetic resonance (MR) T2-weighted sagittal image from 2009.
A – The area of increased signal intensity accompanied with swelling (smooth expansion) of the medulla oblongata, the entire cervical part and the first three
levels of the thoracic part of the spinal cord, that could be attributed to acute longitudinal myelitis. The same sequence on the magnetic resonance imaging
(MRI) of the spine from 2011. B – Newly formed intramedullary lesions of the same MR characteristics, from Th3 downwards making a conus that correlates
with actual clinical findings. Note the chronic atrophic changes of the previously affected medulla oblongata and cervical spine.Strana 1058 VOJNOSANITETSKI PREGLED Volumen 70, Broj 11
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Based on immunological findings – increased RF, posi-
tive ANA, decreased levels of C3 and C4, normal lupus anti-
coagulant (LA) and anti double stranded (anti-ds) DNA anti-
bodies, and positive Schirmer’s test, regarding all previous and
new findings, an immunologist confirmed the diagnosis of SS.
We applied corticosteroid therapy with intravenous
methylprednosolone 1 g daily during six days, switched to
prednisolone 1 mg/kg daily, with good therapeutic response
and gradual recovery of symptoms.
Control MRI of the spine, performed two weeks later, re-
vealed initial regression of pathological changes in spinal cord.
Control LP findings were within normal limits.
The patient was discharged after 18 days on prednisolon
therapy, with her previous deficit (mild hemiparesis and dis-
crete hemihypesthaesia of the left limbs), but incontinent.
Discussion
A wide range of disorders can cause LETM, but usually
the first line diagnosis is NMO 
1. Since the discovery of a spe-
cific serum biomarker, neuromyelitis optica immunoglobulin
G (NMO-IgG), the concept of understanding and definition
NMO has changed 
3. This biomarker distinguishes NMO from
other demyelinating disorders. Based on the detection of this
biomarker in the serum of affected patients, a variety of allied
disorders are grouped under the name of NMO spectrum dis-
orders (NMOSD), also including recurrent myelitis associated
with LETM and optic neuritis or myelitis associated with
autoimmune disorders such as SLE and SS 
4. Recurrent TM
associated with longitudinal spinal cord lesions appear to be
rather NMO-IgG seropositive. NMO-IgG seropositivity after
the first attack predicts a relapsing course in most of the pa-
tients within three years of the first attack 
5.
Sjögren’s syndrome can be complicated with neurologi-
cal problems, and frequently neurological signs are the first
manifestations of SS. According to the study of Delalande et
al.
6, neurological complications are the first symptom of SS in
81% patients, about 35% have spinal cord involvement and
one third of these have acute myelopathy. In some patients,
NMO and non-organ specific autoimmune disorders, particu-
larly SS or SLE, coexist. It is the result of the presence of
NMO-IgG in some patients with SS or SLE who have neuro-
logical involvement 
7.
In the presented case, the first attack of LETM was ini-
tially considered idiopathic, but after confirming the diagnosis
of SS it was assumed as first manifestation of SS. Current
clinical findings and diagnostic procedures excluded sarcoido-
sis, Behcet's disease, SLE, metastatic tumors, viral infection as
possible diagnosis. The patient did not fulfill diagnostic crite-
ria for MS. Devic’s disease was considered unlikely due to the
absence of absolute diagnostic criteria – optic nerve lesions on
MRI, also negative VEP, but subclinical NMO or NMOSD
could not be excluded because we were not able to test NMO-
IgG (not available in our laboratories). In the context of cur-
rent findings, recurrent LETM in the presented case, even
without testing NMO-IgG, made us to conclude that the pre-
sented patient probably had NMOSD.
There have been a few cases in the literature on LETM
and recurrent LETM associated with non-organ specific
autoimmune disorder 
8–10, but, to our knowledge, there have
been no reports on recurrent LETM associated with SS.
Moreover, we found the presented case interesting because in-
spite of the fact that LETM extended to practically entire spi-
nal cord, the patient had good outcome.
Conclusion
A wide range of disorders can cause LETM, but usually
the first line diagnosis is NMO. Based on the detection of
NMO immunoglobulin G in the serum of affected patients, a
variety of allied disorders were grouped under the name of
NMO spectrum disorders, including recurrent myelitis associ-
ated with LETM and myelitis associated with autoimmune
disorders such as SS. There have been only a few cases re-
ported in the literature with recurrent LETM associated with
non-organ specific autoimmune disorder.
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